Cáncer de tiroides en pediatría

  1. Prieto-Matos, Pablo
  2. Martín-Hernández, Diana 1
  3. Martín-Alonso, Montserrat
  4. Bajo-Delgado, Ana Fe
  5. Riesco-Riesco, Susana 2
  6. Prieto-Matos, Carlos
  1. 1 Unidad de Radiología; Hospital Universitario de Salamanca
  2. 2 Unidad de Onco-hematología Pediátrica; Hospital Universitario de Salamanca
Revista:
Revista ORL

ISSN: 2444-7986,  2444-7986

Año de publicación: 2021

Volumen: 12

Volumen: 4

Páginas: 303-312

Tipo: Artículo

DOI: 10.14201/ORL.25061 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: Revista ORL

Objetivos de desarrollo sostenible

Resumen

Thyroid cancer is a rare disease in pediatric age; however it is increasing in the last few years, mainly in adolescent women. Although children and adult thyroid cancer are similar, they have some particular differences. The aim of this report is to analyze those differences, emphasizing the particularities of thyroid cáncer in pediatric age. The development of molecular genetic testing has allowed a deeper understanding of genetic predisposition síndromes, such as MEN2A, which has led to a significant increase in prophylactic thyroidectomies. The most frequent histological group is differentiated cáncer, specifically papilar type. At the time of diagnosis in children thyroid cancer presents a greater size and extensión, and more probabilities of multifocality and metastasis than in adults. The short-term prognosis is excellent; however in the long-term there are a significant number of recurrences and second tumors. It is important to carry out a personalized medicine, and to create diagnostic protocols. A Deep tumor characterization and the prognosis stratification will be essential to choose the correct treatment for each case, also to achieve maximum effectiveness, survival and to minimize side effects.

Referencias bibliográficas

  • Bucsky P, Parlowsky T. Epidemiology and therapy of thyroid cancer in childhood and adolescence. Exp Clin Endocrinol diabetes. 1997;105:70-3.
  • Howlader N, Noone AM, Krapcho M, Miller D, Brest A YM et al. SEER Cancer Statistics Review, 1975–2016.
  • Dermody S, Walls A, Harley EH. Pediatric thyroid cancer: An update from the SEER database 2007-2012. Int J Pediatr Otorhinolaryngol. Octubre de 2016;89:121-6.
  • Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009;115(16):3801-7.
  • Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015;25(7):716-59.
  • Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. Marzo de 1995;141(3):259-77.
  • Karapanou O, Tzanela M, Vlassopoulou B, Kanaka-Gantenbein C. Differentiated thyroid cancer in childhood: a literature update. Horm. 2017;16(4):381-7.
  • Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156(1):167-72.
  • Chan CM, Young J, Prager J, Travers S. Pediatric Thyroid Cancer. Adv Pediatr. 2017;64(1):171-90.
  • Leon Cariñena S, De Mingo Alemany C. M, Macian F KS. Carcinoma papilar de tiroides en la edad pediátrica y adolescencia. Rev Esp Endocrinol Pediatr. 2014;5:204-5.
  • Salamanca Fresno L, Fernánez Menéndez A E, Kadaoui Calvo M, Saiz Rodríguez I RRI, Casado GI. Cáncer de tiroides: experiencia en nuestro centro en los últimos 10 años. Rev Esp Endocrinol Pediatr. 2016;7:80-1.
  • Martín Tejedor BM, Gutierrez Schiaffino G G, Molina E, Leiva Gea I M-AOM, J.P. L-S. ¿Existe el nódulo tiroideo en pediatría?¿Cuándo y cómo buscarlo? Rev Esp Endocrinol Pediatr. 2016;7:160-1.
  • Starenki D, Park J-I. Pediatric Medullary Thyroid Carcinoma. J Pediatr Oncol. 3(2):29-37.
  • Paulson VA, Rudzinski ER, Hawkins DS. Thyroid cancer in the pediatric population. Genes (Basel). 2019;10(9):723.
  • Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. Octubre de 2014;159(3):676-90.
  • Niederle B, Sebag F, Brauckhoff M. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease-a consensus statement of the European Society of Endocrine Surgeons (ESES). Langenbeck’s Arch Surg. 2014;399(2):185-97.
  • Schneider AB, Bekerman C, Leland J, Rosengarten J, Hyun H, Collins B, et al. Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab. 1997;82(12):4020-7.
  • Dinauer C, Francis GL. Thyroid cancer in children. Endocrinol Metab Clin North Am. septiembre de 2007;36(3):779-806, VII.
  • Creo A, Alahdab F, Al Nofal A, Thomas K, Kolbe A, Pittock ST. Ultrasonography and the American Thyroid Association Ultrasound-Based Risk Stratification Tool: Utility in Pediatric and Adolescent Thyroid Nodules. Horm Res Paediatr. 2018;90(2):93-101.
  • Mussa A, De Andrea M, Motta M, Mormile A, Palestini N, Corrias A. Predictors of Malignancy in Children with Thyroid Nodules. J Pediatr. 2015;167(4):886-92.
  • Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14(5):587-95.
  • Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary Thyroid Nodule Evaluation and Management. J Clin Endocrinol Metab. Septiembre de 2020;105(9).
  • Niedziela M, Breborowicz D, Trejster E, Korman E. Hot Nodules in Children and Adolescents in Western Poland from 1996 to 2000: Clinical Analysis of 31 Patients. J Pediatr Endocrinol Metab. 2002;15(6):823-30.
  • Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017;27(11):1341-6.
  • Wang H, Mehrad M, Ely KA, Liang J, Solórzano CC, Neblett WW, et al. Incidence and malignancy rates of indeterminate pediatric thyroid nodules. Cancer Cytopathol. 2019;127(4):231-9.
  • Smith M, Pantanowitz L, Khalbuss WE, Benkovich VA, Monaco SE. Indeterminate pediatric thyroid fine needle aspirations: a study of 68 cases. Acta Cytol. 2013;57(4):341-8.
  • Vassilopoulou-Sellin R, Klein MJ, Smith TH, Samaan NA, Frankenthaler RA, Goepfert H, et al. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer. 1993;71(4):1348-52.
  • Balachandar S, La Quaglia M, Tuttle RM, Heller G, Ghossein RA, Sklar CA. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes. Thyroid. 2016;26(2):219-26.
  • Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34(6):1192-202.
  • Al-Qurayshi Z, Hauch A, Srivastav S, Aslam R, Friedlander P, Kandil E. A National Perspective of the Risk, Presentation, and Outcomes of Pediatric Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2016;142(5):472-8.
  • Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988;104(6):1157-66.
  • Demidchik YE, Demidchik EP, Reiners C, Biko J, Mine M, Saenko VA, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of {Belarus}. Ann Surg. 2006;243(4):525-32.
  • Stevens C, Lee JKP, Sadatsafavi M, Blair GK. Pediatric thyroid fine-needle aspiration cytology: a meta-analysis. J Pediatr Surg. 2009;44(11):2184-91.
  • Ye B, Shi J, Shen C, Wang L, Hu H, Ma Y, et al. Comparison of differentiated thyroid carcinoma recurrence and its clinical features in children of different ages. Oncotarget. Julio de 2017;8(29):48051-9.
  • Tuggle CT, Roman SA, Wang TS, Boudourakis L, Thomas DC, Udelsman R, et al. Pediatric endocrine surgery: who is operating on our children? Surgery [Internet]. 2008 [citado 27 de marzo de 2014];144(6):869-77. Disponible en: http://www.sciencedirect.com/science/article/pii/S0039606008005515
  • Rachmiel M, Charron M, Gupta A, Hamilton J, Wherrett D, Forte V, et al. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab. 2006;19(12):1377-93.
  • Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, et al. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol. 2009;16(12):3442-9.
  • Kim J, Sun Z, Adam MA, Adibe OO, Rice HE, Roman SA, et al. Predictors of nodal metastasis in pediatric differentiated thyroid cancer. J Pediatr Surg. Enero de 2017;52(1):120-3.
  • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
  • Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees S, et al. Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab [Internet]. 2008 [citado 27 de marzo de 2014];93(8):3058-65. Disponible en: http://press.endocrine.org/doi/abs/10.1210/jc.2008-0660
  • Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88(4):1433-41.
  • Luster M, Handkiewicz-Junak D, Grossi A, Zacharin M, Taïeb D, Cruz O, et al. Recombinant Thyrotropin Use in Children and Adolescents with Differentiated Thyroid Cancer: A Multicenter Retrospective Study. J Clin Endocrinol Metab. 2009;94(10):3948-53.
  • Kim A, Widemann BC, Krailo M, Jayaprakash N, Fox E, Weigel B, et al. Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015;62(9):1562-6.
  • Waguespack SG, Sherman SI, Williams MD, Clayman GL, Herzog CE. The successful use of sorafenib to treat pediatric papillary thyroid carcinoma. Thyroid. 2009;19(4):407-12.
  • Moretti S, Menicali E, Nucci N, Guzzetti M, Morelli S, Puxeddu E. Therapy pf endocrine disease: Immunotherapy of advanced thyroid cancer: from bench to bedside. Eur J Endocrinol. 2020;183(2):R41-55.
  • Wells SA, Robinson BG, Gagel RF, Dralle H, Fagin JA, Santoro M, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol. 2012;30(2):134-41.
  • Fox E, Widemann BC, Chuk MK, Marcus L, Aikin A, Whitcomb PO, et al. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin cancer Res. Agosto de 2013;19(15):4239-48.
  • Chen AY, Davies L. Children and thyroid cancer: Interpreting troubling trends. Cancer. 2019;125(14):2359-61.
  • Rossi ED, Mehrotra S, Kilic AI, Toslak IE, Lim-Dunham J, Martini M, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group. Cancer Cytopathol. 2018;126(1):27-35.
  • Kiratli PO, Volkan-Salanci B, Günay EC, Varan A, Akyüz C, Büyükpamukçu M. Thyroid cancer in pediatric age group: an institutional experience and review of the literature. J Pediatr Hematol Oncol. 2013;35(2):93-7.
  • Kirk JM, Mort C, Grant DB, Touzel RJ, Plowman N. The usefulness of serum thyroglobulin in the follow-up of differentiated thyroid carcinoma in children. Med Pediatr Oncol. 1992;20(3):201-8.
  • Scognamiglio T. C Cell and Follicular Epithelial Cell Precursor Lesions of the Thyroid. Arch Pathol Lab Med. 2017;141(12):1646-52.
  • Shepet K, Alhefdhi A, Lai N, Mazeh H, Sippel R, Chen H. Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free Survival. Ann Surg Oncol. 2013;20(5):1451-5.
Fuente de los datos: Dialnet